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Abstract
Objective: To investigate the effect of triglyceride (TG) integrates with plasma major components of
apolipoproteins in HDL subclasses distribution and further elicited the TG-apolipoproteins (apos) interaction in the
processes of high density lipoprotein (HDL) mature metabolic and atherosclerosis related diseases.
Methods: Contents of plasma HDL subclasses were quantities by two-dimensional gel electrophoresis associated
with immunodetection in 500 Chinese subjects.
Results: Contents of preb1-HDL, HDL3a, and apoB-100 level along with apoB-100/A-I ratio were significantly
increased, whereas there was a significant reduction in the contents of HDL2, apoA-I level as well as apoC-III/C-II
ratio with increased TG concentration. Moreover, preb1-HDL contents is elevated about 9 mg/L and HDL2b
contents can be reduced 21 mg/L for 0.5 mmol/L increment in TG concentration. Moreover, with increase of apoA-
I levels, HDL2b contents were marginally elevated in any TG concentration group. Furthermore, despite of in the
apoB-100/A-I < 0.9 group, the contents of preb1-HDL increased, and those of HDL2b decreased significantly for
subjects in both high and very high TG levels compared to that in normal TG levels. Similarly, in the apoB-100/
A-I ≥0.9 group, the distribution of HDL subclasses also showed abnormality for subjects with normal TG levels.
Conclusions: The particle size of HDL subclasses tend to small with TG levels increased which indicated that HDL
maturation might be impeded and efficiency of reverse cholesterol transport(RCT) might be weakened. These data
suggest that TG levels were not only significantly associated with but liner with the contents of preb1-HDL and
HDL2b. They also raise the possibility that the TG levels effect on HDL maturation metabolism are subjected to
plasma apolipoproteins and apolipoproteins ratios.
Background
Several studies were published in the 1970s reporting an
inverse association between plasma high density lipopro-
tein cholesterol (HDL-C) level and coronary heart disease
(CHD) [1], confirmed since then by numerous additional
studies throughout the world. HDL-C was first endorsed as
a formal independent risk factor for CHD in the 1980s and
has since evolved into one of the few “traditional” risk fac-
tors used by clinicians to assess cardiovascular risk.
Because of the association of low HDL-C with other
atherogenic factors, a low HDL-C is not as strongly
independent in its prediction of CHD as suggested by
usual multivariate analysis [2]. Subjects with low HDL-C
display marked changes in their HDL composition and
subclass distribution. Some studies indicate that larger
HDL2 particles as well as HDL mean particle size are
reduced in subjects with low HDL-C [3-7]. Case-control
studies indicate that the inverse relation between HDL-C
levels and CHD is accounted for by the largest HDL parti-
cles, the HDL2b subclass [8]. In addition, familial
low-HDL-C subjects exhibit higher levels of inflammation
markers such as high-sensitivity C-reactive protein
(hsCRP) [9].
HDL metabolism is somewhat more complex than that
of the other major lipoprotein fractions. It is well known
that HDL does not represent a sum of identical particles
but is rather comprised of discrete subclasses that differ
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any medium, provided the original work is properly cited.related to charge, density, size, composition, shape and
physiological functions [10]. Using two-dimensional gel
electrophoresis coupled with immunoblotting, HDL can
be divided into large, cholesterol-rich (HDL2a and
HDL2b), small-sized (HDL3c,H D L 3b,H D L 3a,a n dp r e b1-
HDL) and preb2-HDL [11,12]. Epidemiological studies
have shown that individual HDL subclasses are not
equally atheroprotective [13], a decrease content of the
large-sized HDL2b particles and an increase content of
the small-sized preb1-HDL particles were highly and sig-
nificantly associated with the risk of CHD [14,15].
Our laboratory had investigated the effect of plasma tri-
glyceride (TG) and total cholesterol (TC) on the distribu-
tion of the HDL subclasses. The findings demonstrated
that plasma increased TG and TC concentrations cause
the particles size of HDL subclasses tend to smaller, creat-
ing an environment of diminished reverse cholesterol
reverse cholesterol transport(RCT)[12,16-18]. The elevated
TG levels are usually not only accompanied by other lipid
metabolic disturbance but also associated with the change
in plasma apolipoprotein levels. The TG and other lipids
have been extensively studied for their effect on HDL sub-
classes distribution. Less information is known regarding
the impact of TG combine with plasma apolipoproteins
on profile of HDL subclasses distribution.
In this study, we mainly focused on the effect of TG inte-
grate with plasma major components of apolipoproteins in
HDL subclasses contents distribution and further elicited
the TG-apolipoproteins interaction in the processes of
HDL mature metabolism.
Results
Concentrations of plasma lipids, apolipoproteins, and
ratios of lipids and apolipoproteins among subjects
classified by levels of TG
Table 1 showed that in the population, the concentration of
TG was 2.1 ± 0.3 mmol/L which exceeds normal TG levels
recommended in the ATP-III of NCEP guidelines that indi-
cated a substantial proportion of subjects with hypertrigly-
ceridemia (HTG). Moreover, the body mass index(BMI)
was increased with the elevation of the TG levels and the
subjects in borderline-high, high and very high TG groups
were characterized by an adverse lipid profile which
comprised of increased concentrations of TG, TC, low den-
sity lipoprotein cholesterol(LDL-C) and levels of apoB-100,
apoC-II, and apoC-III along with the ratios of TG/HDL-C,
TC/HDL-C,LDL-C/HDL-C, and apoB-100/A-I; however,
lower levels of HDL-C, apoA-I and apoC-III/C-II ratio
compared with normal TG subjects.
The apoA-I contents of HDL subclasses among subjects
categorized based on levels of TG
Characteristics of the HDL subclass contents distribution
profile were displayed in Table 2. The contents of small-
Table 1 Concentrations of plasma lipids, apolipoproteins, and ratios of lipids, and apolipoproteins among subjects
categorized by TG levels
Total
(n = 500)
Normal TG
(n = 202)
Borderline-high TG
(n = 77)
High TG
(n = 183)
Very high TG
(n = 38)
Age(yr) 56.7 ± 9.0 55.6 ± 9.7 55.8 ± 8.7 57.3 ± 9.2 58.6 ± 9.0
Female/male 175/325 72/130 26/51 64/119 13/25
Sex ratio(%) 53.8 55.4 50.9 53.8 52.0
BMI(kg/m
2) 23.4 ± 2.2 22.4 ± 2.5 23.4 ± 2.8 24.5 ± 2.8
a§ 26.2 ± 3.0
a§ b§
TG(mmol/L) 2.1 ± 0.3 1.0 ± 0.2 1.9 ± 0.2
a§ 3.3 ± 0.8
a§ b§ 7.1 ± 1.0
a§ b§ c§
TC(mmol/L) 5.4 ± 0.9 5.0 ± 0.8 5.2 ± 0.9 5.5 ± 0.9
a‡ 6.1 ± 0.8
a§ b§ c‡
LDL-C(mmol/L) 3.3 ± 0.4 2.8 ± 0.7 3.0 ± 0.8 3.4 ± 0.8
a‡b* 3.5 ± 0.9
a‡b‡
HDL-C(mmol/L) 1.2 ± 0.3 1.6 ± 0.3 1.3 ± 0.4
a§ 1.0 ± 0.4
a§b§ 0.9 ± 0.2
a§b§
ApoA-I(mg/L) 1270.2 ± 102.5 1319.1 ± 193.8 1300.0 ± 178.4 1257.2 ± 151.2 1187.9 ± 123.2
a‡ b‡ c*
ApoB-100(mg/L) 905.6 ± 98.4 804.3 ± 97.7 905.6 ± 108.4
a‡ 1015.4 ± 119.1
a§ b‡ 1167.2 ± 113.9
a§ b§ c‡
ApoC-II(mg/L) 62.5 ± 10.8 45.4 ± 9.5 66.7 ± 11.9
a* 101.9 ± 17.3
a§ b‡ 140.2 ± 25.3
a§ b§ c‡
ApoC-III(mg/L) 150.2 ± 25.6 112.9 ± 21.9 152.3 ± 23.2
a§ 196.8 ± 27.5
a§ b§ 252.4 ± 29.8
a§ b§ c§
TG/HDL-C 2.1 ± 0.2 0.8 ± 0.2 1.3 ± 0.3
a§ 3.5 ± 0.9
a§b§ 5.4 ± 0.9
a§ b§c§
TC/HDL-C 4.8 ± 0.3 4.0 ± 1.0 4.7 ± 1.0
a* 5.7 ± 1.0
a§b‡ 6.1 ± 1.1
a§ b§
LDL-C/HDL-C 2.8 ± 0.2 1.3 ± 0.2 1.8 ± 0.3
a‡ 2.6 ± 0.5
a§b‡ 3.0 ± 0.9
a§ b§c*
ApoB-100/A-I 0.7 ± 0.2 0.4 ± 0.1 0.5 ± 0.2 0.8 ± 0.2
a§b‡ 1.1 ± 0.3
a§ b§c‡
ApoC-III/C-II 2.4 ± 0.3 2.5 ± 0.3 2.3 ± 0.2 1.9 ± 0.2
a§b‡ 1.8 ± 0.2
a§b‡
Values are expressed as Mean ± S.D.
*P< 0.05,
‡P< 0.01,
§P< 0.001.
aSignificantly different from Normal TG group.
bSignificantly different from Borderline-high TG group.
cSignificantly different from High TG group.
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Page 2 of 10sized particles preb1-HDL, HDL3a were significantly
increased, whereas there was a significant reduction in
the contents of large-sized particles HDL2a,a n dH D L 2b
with the increased of TG levels. Furthermore, the con-
tents of other HDL subclasses had no marked difference
in borderline-high, high and very high TG subjects vs.
the corresponding normal TG subjects.
Relations of the preb1-HDL and HDL2b contents to the
levels of TG
To investigate the degree of HDL subclasses change
with the levels of TG varied, we divided the levels of
TG into 9 strata and using each stratum TG median
value as x axis, with every stratum TG corresponding
the median preb1-HDL and HDL2b contents as y axis to
plot (Figure 1).The figure shows associations of TG
levels with increased preb1-HDL contents and with
decreased HDL2b contents.
Profile of preb1-HDL and HDL2b contents distribution in
accordance with the TG together with ApoA-I levels
Regardless of elevated TG and/or apoA-I, preb1-HDL
contents were obviously increased Figure 2(1); The simi-
lar results observed that in each same TG group, HDL2b
contents were marginally elevated accompanied with the
increase of apoA-I levels. On the contrary, in any apoA-
I levels, contents of HDL2b were apparently decreased as
the elevation of TG levels. Moreover, the lowest
Table 2 The apoA-I contents of HDL subclasses among subjects categorized by TG levels
Normal TG
(n = 202)
Borderline-high TG
(n = 77)
High TG
(n = 183)
Very high TG
(n = 38)
Preb1-HDL(mg/L) 80.6 ± 11.4 104.9 ± 17.8
a* 129.5 ± 21.9
a§b‡ 153.0 ± 27.8
a§b‡ c*
Preb2-HDL(mg/L) 51.6 ± 8.6 58.9 ± 7.9 61.4 ± 8.7 64.9 ± 9.0
HDL3c(mg/L) 68.8 ± 9.2 71.4 ± 9.6 74.3 ± 9.0 75.8 ± 9.0
HDL3b(mg/L) 138.7 ± 20.7 143.7 ± 23.6 148.4 ± 21.9 151.4 ± 27.0
HDL3a(mg/L) 238.7 ± 30.6 285.5 ± 28.7
a‡ 310.9 ± 31.7
a§b* 384.2 ± 40.1
a§b§c§
HDL2a(mg/L) 292.7 ± 27.5 267.9 ± 24.1
a* 227.5 ± 29.6
a§b‡ 202.4 ± 23.4
a§b§c*
HDL2b(mg/L) 379.8 ± 57.8 319.3 ± 46.6
a§ 255.3 ± 27.3
a§b§ 219.3 ± 26.5
a§b§c‡
Values are expressed as Mean ± S.D.
*P< 0.05,
‡P< 0.01,
§P< 0.001.
aSignificantly different from Normal TG group.
bSignificantly different from Borderline-high TG group.
cSignificantly different from High TG group.
Figure 1 The contents of preb1-HDL and HDL2b according to approximately equal ninths of baseline TG for the entire study
population.
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apoA-I group (152.2 ± 23.8 mg/L) in terms of the gra-
phic information represented in Figure 2(2).
Changes of preb1-HDL and HDL2b contents distribution
based on the levels of TG and ApoB-100/A-I ratio
We use a suggested cut-point value of 0.9 for the apoB-
100/apoA-I ratio to further dichotomized analyze the
effect of TG concentration combined with ApoB-100/A-
Ir a t i oo np r o f i l eo fp r e b1-HDL and HDL2b distribution
[Figure 3(A) and 3(B)]. The results presented that both
of apoB-100/A-I < 0.9 and apoB-100/A-I ≥ 0.9 groups,
the contents of preb1-HDL were increased significantly
while the contents of HDL2b were obviously lower with
a rise in TG concentrations.
It is noteworthy, the reduction of HDL2b contents
(151.0 ± 21.3 mg/L) even exceed the elevation of preb1-
HDL contents(183.9 ± 28.7 mg/L) which resulted in a
reduction of HDL2b/preb1-HDL ratio (0.8) for subjects
with very high TG-ApoB-100/A-I ≥0.9.
Figure 2 The contents of preb1-HDL(1) and HDL2b(2) according to TG and apoA-I concentration for the whole subjects.* P< 0.05, **P<
0.01, ***P< 0.001, compared with the low apoA-I subgroup within the same TG group
§§P< 0.01,
§§§P< 0.001, compared with the normal TG
subgroup within the same apoA-I group.
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ratios, and the contents of HDL subclasses after
controlling for apoA-I, apoB-100
Table 3 shows correlations between the contents of
HDL subclasses and conventional lipid parameter when
controlling for apoA-I, and apoB-100. Specifically, the
concentrations of TG, TC, LDL-C, and the ratios of
TG/HDL-C, TC/HDL-C, as well as LDL-C/HDL-C were
highly positively correlated with preb1-HDL and HDL3a
while being negatively associated with HDL-C
Figure 3 The contents of preb1-HDL and HDL2b for TG combine with apoB-100/A-I(A) and TG combine with apoB-100/A-I(B),
respectively.* P< 0.05, **P< 0.01, ***P< 0.001, compared with the normal TG subgroup.
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Page 5 of 10concentration. The contents of HDL2a and HDL2b were
inversely associated with TG and the ratios of TG/HDL-
C, TC/HDL-C along with LDL-C/HDL-C but positively
related to HDL-C concentration. With respect to other
HDL subclasses, the concentrations of TG, TC, LDL-C,
and the ratios of TC/HDL-C, LDL-C/HDL-C were posi-
tively correlated with HDL3b.
Discussion
Many prospective studies have reported a positive rela-
tionship between levels of TG and incidence of CHD
[19,20]. However; early multivariate analyses generally
did not identify plasma TG as an independent risk fac-
tor for CHD [21]. Lipoprotein metabolism is integrally
linked with, and elevations of plasma TG can be
confounded by significant correlations with LDL and
HDL-C levels. Nonlipid risk factors of obesity, cigarette
smoking also integrated with TG as are several emerging
risk factors [22]. Therefore, many persons with elevated
TG are at increased risk for CHD, even when this
greater risk can not be independently explained by TG.
It is well known that the most common hyperlipide-
mia for the Chinese population was characterized by
elevated TG levels, which was much more prevalent
(61% of total hyperlipidemia) than high TC [11]. Liu
[23] suggested that higher levels of TG in China were
induced by high-carbohydrated i e t so ft h ep o p u l a t i o n s .
Sugars and grains require insulin secretion, which is a
potent stimulus to the liver to produce TG. We assessed
the alteration of TG levels by Adult Treatment Panel III
(ATP-III) guidelines [24] and HDL subclasses particle
size using two-dimensional electrophoresis immunode-
tection. The data displayed that with the elevation of
TG levels, the subjects have an atherogenic dyslipidemia
phenotype comprising of an increased of TG, TC, LDL-
C and apoB-100,C-II, C-III along with the ratios of TG/
HDL-C, TC/HDL-C,LDL-C/HDL-C, and apoB-100/A-I,
coupled with a decreased of HDL-C, apoA-I as well as
apoC-III/C-II ratio. Meanwhile, elevated TG concentra-
tions were related to the higher contents of small-sized
(preb1-HDL and HDL3a) and the lower contents of
large-sized HDL (HDL2a and HDL2b). Further, for
grouped analyses, individuals were classified according
to approximately equal ninths of baseline TG for the
entire study population (_0.7, 0.8-1.0, 1.1-1.4, 1.5-1.8,
1.9-2.3, 2.4-2.8, 2.9-3.4, 3.5-4.8, and ≥ 4.8 mmol/l).
Trends in mean values of major HDL subclasses (preb1-
HDL and HDL2b) across these ninths were assessed
through simple linear regression, in this models with the
contents of preb1-HDL and HDL2b as the dependent
variable and the levels of TG levels as independent vari-
able, our results revealed that preb1-HDL contents is
elevated about 9 mg/L and HDL2b contents can be
reduced 21 mg/L for 0.5 mmol/L increment in TG.
Many studies have established that with the elevation
of plasma TG concentration and the reduction of HDL-
C concentration, cholesteryl ester transfer protein
(CETP) and hepatic lipase (HL) activities were
strengthen[25]. Through the actions CETP, intravascular
exchange of neutral lipids and apos occurs between
apoB-containing lipoprotein(LDL), intermediate density
lipoprotein (IDL), very low density lipoprotein (VLDL),
chylomicrons (CM), and remnants and HDL. Thus, ele-
vated TG leads to the generation of TG-rich HDL parti-
cles, which are more susceptible to modification by HL
[26]. HL has greater activity against HDL and converts
larger HDL particles to smaller HDL particles. The
higher concentration TG and the lower concentration of
HDL-C associated with increased HDL catabolism,
another is a reduction in lipoprotein lipase (LPL) and
lecithin cholesterolacyl transferase (LCAT) activities.
The activity of LCAT catalyzes the transfer of 2-acyl
groups from lecithin to free cholesterol (FC), generating
cholesterol ester (CE) and lysolecithin. Hydrophobic CE
is retained in the HDL core forming larger mature HDL
particles [27]. LPL has predominantly TG lipase activity,
In the process of hydrolyzing TG-rich lipoprotein(TRL),
CM and VLDL release TG, TC, phospholipids, apoA-I
and apoCs, subsequent binding of these products to
HDL3 results in formation of HDL2 particles. This mod-
ification leads to the formation of smaller HDL particles,
which may impair its cardioprotective function.
Table 3 Correlation coefficients between plasma lipids, lipids ratios and HDL subclasses contents (Controlling for
ApoA-I, ApoB-100)
TG TC LDL-C HDL-C TG/HDL-C TC/HDL-C LDL-C/HDL-C
t P t P t P t P t P t P t P
Preb1-HDL .448 .000 .186 .000 .006 .897 -.269 .000 .439 .000 .374 .000 .152 .001
Preb2-HDL .147 .001 .029 .525 .047 .301 -.052 .254 .141 .001 .114 .012 .035 .446
HDL3c .011 .209 .099 .028 .063 .164 .083 .067 .025 .587 .021 .643 .005 .912
HDL3b .006 .899 .183 .000 .176 .000 -.030 .507 .005 .915 .116 .011 .147 .001
HDL3a .288 .000 -.119 .009 -.176 .000 -.253 .000 .314 .000 .233 .000 .065 .156
HDL2a -.211 .000 .059 .192 .097 .033 .207 .000 -.214 .000 -.164 .000 .049 .280
HDL2b -.296 .000 -.146 .001 -.019 .674 .281 .000 -.314 .000 -.310 .000 -.165 .000
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metabolic disorder in the elevated TG concentrations
condition could be involved in the plasma apolipopro-
tein levels alter. We divided the apoA-I concentrations
into tertiles and to investigate the influence of TG com-
bined with apoA-I levels on phenotype of HDL sub-
classes distribution. Our findings presented that
regardless of elevated TG and/or apoA-I, preb1-HDL
contents were obviously increased; Likeness, in any TG
levels, the contents of HDL2b significantly and gradually
increased with elevated of apoA-I levels, which sug-
gested that the protective effect of increased apoA-I
levels against the reduction of HDL2b caused by elevated
TG concentration. Other researchers have found that
during severe sepsis or chronic inflammation, pro-
inflammatory cytokine and TG levels are increased,
while Apo-AI, Apo-B levels are decreased [28-31]. Cyto-
kines have a major role in stimulating the production of
acute phase proteins (APP) as part of the host immune
response to infection, but prolonged inflammatory
immune responses may be harmful to the host. Like
albumin, Apo-AI is classified as a negative APP. While
the role of negative APP is unclear, reduced levels of
negative APP with anti-inflammatory activity, such as
Apo-AI and transthyretin, may promote pro-inflamma-
tory responses [32].
Studies in human apoA-I transgenic mice have
showed that the distribution of apoA-I among the HDL
subclasses was similar, suggesting that the content of
apoA-I in the major HDL subspecies was fixed [33] and
the apoA-I levels might reflect of the amount or number
of HDL particles, and with the elevation of apoA-I
levels, molecules of apoA-I distributed to each of the
subclasses increased which resulted in all HDL sub-
classes tend to increase. In addition, apoA-I not only is
activator of LCAT but also is a critical ligand of the
HDL receptor scavenger receptor BI (SR-BI) and the
interaction of apoA-I and SR-BI may facilitate hepatic
selective uptake of HDL-C in the RCT pathway. In
agreement with these, our previous study have reported
that with increased plasma apoA-I concentration, the
contents of all HDL subclasses rose significantly, with
t h ei n c r e a s ei nl a r g e - s i z e dH D L 2b being the most
significant.
The large prospective apolipoprotein-related Mortality
Risk (AMORIS) study [34] suggests that apoB-100,
apoA-I and the apoB-100/apoA-I ratio should be
regarded as highly predictive in evaluating cardiac risk
[34,35]. A series of studies have shown that an apoB-
100/apoA-I ratio ≥0.9 was a fair predictor of presence of
the metabolic syndrome (MetS) [36], and men with an
apoB-100/apoA-I ratio > 0.9 had also a faster growth of
carotid artery intima-media thickness (IMT) than those
below this value [37]. In the previous work, we use a 0.9
cut-point for the apoB-100/A-I ratio to dichotomized
analyze the alteration of HDL subclasses distribution
and found that preb1-HDL contents were higher while
HDL2a,H D L 2b contents were lower for subjects with
apoB-100/apoA-I ratio ≥0.9 than that for subjects with
apoB-100/apoA-I ratio < 0.9, which suggests that apoB-
100/A-I ratio might be a strong marker to HDL sub-
classes distribution, moreover, it could reflect sensitivity
the alteration of HDL2b/preb1-HDL values[38].
On the basis of this, we further discussed the effect
of TG interact with apoB-100/apoA-I ratio ≥ 0.9 and
apoB-100/apoA-I ratio < 0.9, separately on HDL sub-
classes distribution. The results obtained in the present
work presented that, the preb1-HDL contents increased
significantly and the HDL2b contents decreased signifi-
cantly as the elevation of TG concentration despite the
subjects with the apoB-100/apoA-I ratio < 0.9. At
the same time, in comparison with the normal TG, the
marked lower values of HDL2b/preb1-HDL in both
high and very high TG groups (5.3 vs 2.3, 1.7). Simi-
larly, in the apoB-100/apoA-I ratio ≥ 0.9, the HDL
subclasses distribution might be reversed for subjects
with normal TG concentration. A low HDL2b/preb1-
HDL ratio is a signature type of disturbed HDL meta-
bolism and RCT and the cholesterol balance deter-
mined as the apoB-100/apoA-I ratio has repeatedly
been shown to be a better index for risk assessment of
CHD. The higher the value of the apoB-100/apoA-I
ratio, the more cholesterol is circulating in the plasma
compartment and this cholesterol is likely to be depos-
ited in the arterial wall, provoking atherogenesis and
risk of coronary vascular (CV) events. From the point
of view of HDL subclasses distribution, all these find-
ings revealed that when evaluation the CHD risk, rely-
ing only on apoB-100/apoA-I values for subjects might
be inadequate and the concentration of TG should be
concerned.
Besides, it is interesting to find that despite the levels
of apoC-II and apoC-III increased, and an increasing in
apoC-II more prominent than in apoC-III which con-
duces to the apoC-III/C-II ratio declined accompany
with the elevation of TG concentration (Table 1). Sasaki,
et al [39]. reported that high carbohydrate feedings
caused decreased HDL-C and apoA-I concentrations
were associated with reduced levels of apoC-III but
increased concentrations of apoC-II in HDL2.I nv i t r o
investigation have exhibited that high levels of apoC-II
have inhibited LPL activity rather than stimulated it
[40]. The diets high in carbohydrate are prevalent in
China, which may result in disorder of TG metabolism
(excessive production and/or deficient clearance) Based
on this, the high carbohydrate diets induced HTG
usually accompanied with the apoC-III/C-II ratio
decreasing, and the apoC-III/C-II ratio seems to play an
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Chinese population.
Conclusions
In summary, we have shown that the particle size of
HDL subclasses tend to small with increasing TG con-
centration which indicated that HDL maturation might
be impeded and efficiency of RCT might be weakened.
These data suggest that TG levels were not only signifi-
cantly associated with but liner with the contents of
preb1-HDL and HDL2b. They also raise the possibility
that TG levels effect on HDL maturation metabolism
are subjected to plasma apos and apos ratios.
Methods
Subjects
Five hundred subjects (325 men; mean age, 56.3 ±
7.2 years; 175 women; mean age, 56.5 ± 8.1 years) were
recruited to participate in a study examining plasma
lipid and apo concentrations at West China Medical
Center, Sichuan University. Exclusion criteria were the
following: (1) the presence of nephrosis, diabetes melli-
tus, hypothyroidism, or hepatic impairment; (2) the pre-
sence of a major cardiovascular event (myocardial
i n f a r c t i o n ,s e v e r eo ru n s t a b l ea n g i n ap e c t o r i s ,a n ds u r -
gery) or stroke; (3) taking lipid-altering medications in
the previous 1 month; or (4) a history of alcohol abuse
and smoking cigarettes. Women were excluded if they
had undergone a hysterectomy with or without an
oophorectomy, or were postmenopausal and receiving
hormone replacement therapy. Informed consent was
obtained from each subject upon entry into the study
population. This study protocol was approved by the
ethics committee.
To study the TG role in the profile of HDL subclasses
distribution, we divided these subjects into four sub-
groups according to plasma TG levels, that is normal
(< 1.69 mmol/L), borderline-high (1.69-2.25 mmol/L),
high (2.26-5.64 mmol/L), and very high (≥5.65 mmol/L)
which were defined by following guidelines from the
ATP-III of the National Cholesterol Education Program
(NCEP) [24]. Moreover, the change in apoA-I, and
apoB-100/A-I ratio associated with the phenotype of
HDL subclass distribution were also investigated in the
current work. The apoA-I concentration was entered as
a categorical variable with three levels. Firstly, the apoA-
I was arranged in ascending sequence on basis of its
concentrations, next the number first to 167th subjects
were designated as lowest tertile of apoA-I group; 168th
to 334th subjects were designated as middle tertile of
apoA-I group, and the 335th to 500th subjects were
designated as the highest tertile of apoA-I group.
Specimens
Whole blood specimens were drawn after a 12-hour
overnight fast into EDTA-containing tubes. Plasma was
separated within 1-2 hours. Plasma was stored at 4°C
and used within 24 hour for lipid and apolipoprotein
analyses. An aliquot of plasma was stored at -70°C for
the determination of HDL subclasses.
Plasma lipid and apolipoprotein analyses
Plasma TG, TC and HDL-C were measured by stan-
dard technique. TC and TG were determined with
enzymatic kits (Beijing Zhongsheng Biotechnological
Corporation, Beijing). HDL-C was determined after
precipitation of the apoB-containing lipoproteins by
phosphotungstate/magnesium chloride [41]. LDL-C
was calculated using Friedwald formula (TG < 4.52
mmol/L) [42]. When plasma TG ≥ 4.52 mmol/L, LDL-
C was determined following precipitation method with
polyvinylsulfate (enzymatic kits). Plasma apoA-I, B-100
were determined by radial immunodiffusion methods
[43] using kits developed at the apolipoprotein
Research Laboratory, West China medical Center,
Sichuan University. The intra-assay coefficient varia-
tions for apolipoprotein concentrations were between
2.1 and 4.8%, inter-assay coefficient of the variations
was 3.5 to 7.9% [44].
High-density lipoprotein cholesterol subclass analyses
ApoA-I-containing HDL subclasses were measured by
nondenaturing two-dimensional gel electrophoresis asso-
ciated with immunodetection method as described pre-
viously [45]. Briefly, 10 μl of plasma was first separated
by charge on 0.7% agarose gel, into preb and a mobility
particles. In the second dimension, the 2 fractions of
HDL were further separated according to size by 2-30%
nondenaturing polyacrylamide gradient gel electrophor-
esis. To determine HDL subclasses, western blotting was
conducted after electrophoresis, using horseradish per-
oxidase (HRP)-labeled goat anti-human apoA-I immu-
noglobulin G (IgG). HDL particle sizes were calibrated
using a standard curve that includes bovine serum albu-
min, ferritin and thyroglobulin (Pharmacia Uppsala,
Sweden). The calculation of each HDL subclass relative
percentage (%) was based on the density of electrophor-
esis spots. Then the apoA-I contents (mg/L) of the HDL
subclasses were calculated by multiplying the percentage
of each subclass by the plasma total apoA-I concentra-
tions. The inter-assay coefficient of variations of the
relative concentration of preb1-HDL, preb2-HDL,
HDL3c,H D L 3b,H D L 3a,H D L 2a,a n dH D L 2b in plasma
sample were 9.4%, 9.8%, 4.9%, 6.2%, 7.3%, 11.1% and
7.9%, respectively (n = 5).
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All statistical analysis was performed using the statistical
package SPSS Version 11.0 (SPSS Inc). Data are
expressed as mean ± S.D. The significant differences
between two groups were analyzed by one-way analysis
of variance (ANOVA). Linear regression was used to
examine the associations between plasma lipids, lipids
ratios and other variables. In all comparisons, P<0 . 0 5
(2-sided) was regarded as statistically significant.
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